No offence but that sounds delusional.
Demoralisation of shareholders is due to the actions of a company where they focus more on marketing themselves to keep up with the constant funding cycles rather than focusing on monetising their IP as efficiently as possible.
You raised a good question. Why do they have a marketing department? They don't have anything to sell. Are 10m a quarter in staff wages in line with a small R&D based device company? Wayne and management have experience in large pharma companies, but AVR isn't one. They need to learn to crawl before they can walk.
Ann: Trading Halt, page-57
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.25 |
Change
-0.250(1.61%) |
Mkt cap ! $322.3M | |||
| Open | High | Low | Value | Volume |
| $15.50 | $15.50 | $14.80 | $140.4K | 9.315K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 297 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.25 | 1300 | 2 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |